SampleTyple | Plasma,Serum,Cellculturesupernatant,otherbodyfluid |
Contents | |
Method | Colorimetricmethodat490nm |
StandardCurve | |
Sensitivity | 60µM-3000µM |
ReactionTime | 30minutes |
Applications | ForBIOLOGicalresearch: |
Storage | -80°C |
Notes | Materialsneededbutnotsupplied Aplatereadercapableofmeasuringabsorbancebetween470-490nm AdjustablePipettesandarepeatpipettor Asourceofpurewater;glassdistilledwaterofHPLC-gradewaterissufficient 0.5MAceticAcid Clearflatbottom96-wellplatesifnotincludedinthekitpurchased |
Shipping | Icepacks |
ReagentPreparation
AssayProtocol
MaterialSafetyDataSheet
Date:Oct26,2015
1.PRODUCTANDCOMPANYIDENTIFICATION
1.1Productidentifier
Productname:D-LactateAssayKit
CatalogNo:1200021002,120002100A,120002100P,1200022002,120002200A,12002200P,1200024002,120002400A,120002400P
1.2Relevantidentifiedusesofthesubstanceormixtureandusesadvisedagainst
Forresearchuseonly.
1.3Detailsofthesupplierofthesafetydatasheet
Company:EtonBioscienceInc
TollFree:1-800-758-1630
Tel:1-800-758-1630
Fax:1-800-507-2912
1.4Emergencytelephonenumber
1-800-758-1630
2.HAZARDSIDENTIFICATION
2.1Classificationofthesubstanceormixture
Notahazardoussubstanceormixture
2.2GHSLabelelements,includingprecautionarystatements
Notahazardoussubstanceormixture
2.3Otherhazards
None
3.COMPOSITION/INFORMATIONONINGREDIENTS
3.1Substances
D-lactateAssaySolution | |||||
Components | CAS# | ||||
DMSO | 67-68-5 | ||||
D-LDH | 9028-36-8 | ||||
Tris-HCl,pH7.5 | N/A | ||||
Water | 7732-18-5 | ||||
D-LactateAssayStandard | |||||
Components | CAS# | ||||
SodiumD-Lactate | 920-49-0 | ||||
Tris-HCl,pH7.5 | N/A | ||||
Water | 7732-18-5 | ||||
EyeProtection | Wearsafetygoggles |
SkinProtection | Wearprotectiveclothing |
HandProtection | Wearprotectivegloves |
Respiratoryprotection | WearNIOSH/MSHAapprovedrespirators |
9.PHYSICALANDCHEMICALPROPERTIES
9.1Informationonbasicphysicalandchemicalproperties
L-LactateAssaySolution
Appearance | Liquid,yellowish |
pH | 7.5 |
Meltingpoint | Nodataavailable |
Freezingpoint | Nodataavailable |
Boilingpoint | Nodataavailable |
Density | Nodataavailable |
Watersolubility | Soluble |
L-LactateStandard
Appearance | Liquid,colorless |
pH | 7.5 |
Meltingpoint | Nodataavailable |
Freezingpoint | Nodataavailable |
Boilingpoint | Nodataavailable |
Density | Nodataavailable |
Watersolubility | Soluble |
9.2Othersafetyinformation
Nodataavailable.
10.STABILITYANDREACTIVITY
10.1Reactivity
Nodataavailable
10.2Chemicalstability
Stableunderrecommendedstorageconditions.
10.3Possibilityofhazardousreactions
Nodataavailable.
10.4Conditionstoavoid
Nodataavailable
10.5IncompatIBLematerials
Strongoxidizingagents
10.6Hazardousdecompositionproducts
Hazardousdecompositionproductsformedunderfireconditions:carbonoxides
11.TOXICOLOGICALINFORMATION
11.1Informationontoxicologicaleffects
Toxicologicaleffectsonthisproducthavenotbeenthoroughlystudied.
12.ECOLOGICALINFORMATION
12.1Toxicity
Avoidreleaseintoenvironment
12.2Persistenceanddegradability
Nodataavailable
12.3.Bioaccumulativepotential
Nodataavailable
12.4Mobilityinsoil
Nodataavailable
12.5ResultsofPBTandvPvBassessment
Nodataavailable
12.6Otheradverseeffects
Nodataavailable
13.DISPOSALINFORMATION
13.1Wastetreatmentmethods
Disposeinaccordancewithlocal,state,andfederalregulations.
14.TRANSPORTINFORMATION
DOT:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
IATA:
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
ADR/RID
Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
15.REGULATORYINFORMATION
EURiskandSafetyphrases:
R36/37/38:irritatingtoeyes/respiratorysystem/skin
16.OTHERINFORMATION
Theinformationaboveisbelievedtobeaccurateandrepresentsthebestinformationcurrentlyavailabletous.However,wemakenowarrantyofmerchantabilityoranyotherwarranty,expressorimplied,withrespecttosuchinformation.EtonBioscienceInc.shallnotbeheldliableforanydamagesorotherconsequencesresultingfromhandlingorfromcontactwiththeaboveproduct.Q.WillD-LactateassaykitmeasureL-Lactate?
A.Noitwont
Everest Biotech公司成立于2000年,由英国牛津大学一批生物化学家创建。公司科学家团队具有丰富的抗体纯化及蛋白组学专业知识,雄厚的专业背景赋予了公司能为全球科研人员提供高质量、创新性抗体产品的能力。目前,Everest Biotech可提供3000余种抗体,涉及肿瘤、自身免疫、过敏、心血管疾病、传染病、代谢、神经科学等领域。所有抗体均由Everest Biotech自主研发生产、全部经过肽亲和纯化以保证最佳的特异性和纯度、经过免疫原肽的ELISA和WB实验验证; 由PhD科学家团队提供全方位技术支持服务。Everest Biotech为众多国际知名抗体公司提供OEM服务。